Patent ID: 7893021

Claim:
A method for treating or delaying a disease or disorder associated with excessive bone mineral loss in a mammal, wherein the mammal is presently undergoing PTH agonist therapy, which method comprises administering to a mammal, to which such treatment or delay is needed or desirable, an effective amount of a parathyroid hormone (PTH) antagonist, wherein the PTH antagonist is a protein or a peptide, selected from the group consisting of PTH 2-84 , PTH 3-84 , PTH 4-84 , PTH 5-84 , PTH 6-84 , PTH 7-84 , PTH 8-84 , PTH 9-84 , PTH 10-84 , PTH 11-84 , PTH 12-84 , PTH 13-84 , PTH 14-84 , PTH 15-84 , PTH 16-84 , PTH 17-84 , PTH 18-84 , PTH 19-84 , PTH 20-84 , PTH 21-84 , PTH 22-84 , PTH 23-84 , PTH 24-84 , PTH 25-84 , PTH 26-84 , PTH 27-84 , PTH 28-84 , PTH 29-84 , PTH 30-84 , PTH 31-84 , PTH 32-84 , and PTH 33-84 , whereby said disease or disorder associated with excessive bone mineral loss is treated or delayed.